Kentucky Retirement Systems Invests $2.24 Million in DaVita Inc. $DVA

Kentucky Retirement Systems purchased a new stake in shares of DaVita Inc. (NYSE:DVA) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 14,575 shares of the company’s stock, valued at approximately $2,240,000.

Other large investors have also recently made changes to their positions in the company. Kesler Norman & Wride LLC lifted its holdings in DaVita by 0.8% during the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock valued at $1,048,000 after purchasing an additional 55 shares in the last quarter. Gen Wealth Partners Inc increased its stake in shares of DaVita by 10.0% in the fourth quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock worth $100,000 after purchasing an additional 80 shares in the last quarter. NewEdge Advisors LLC increased its stake in shares of DaVita by 20.8% in the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after purchasing an additional 88 shares in the last quarter. Orion Porfolio Solutions LLC raised its position in shares of DaVita by 4.4% during the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock valued at $268,000 after purchasing an additional 99 shares during the period. Finally, Root Financial Partners LLC raised its position in shares of DaVita by 128.0% during the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after purchasing an additional 105 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the transaction, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the transaction, the insider owned 109,194 shares of the company’s stock, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 1.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft upgraded DaVita from a “hold” rating to a “buy” rating and increased their price target for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. Zacks Research cut DaVita from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a research note on Monday, June 8th. UBS Group increased their price objective on shares of DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a report on Friday, July 10th. Finally, TD Cowen lifted their price objective on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Two investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, DaVita currently has a consensus rating of “Hold” and a consensus price target of $216.50.

DaVita Stock Performance

Shares of DVA opened at $239.19 on Friday. The stock has a market capitalization of $15.36 billion, a PE ratio of 22.19, a P/E/G ratio of 0.79 and a beta of 0.88. The company’s fifty day moving average is $216.92 and its 200 day moving average is $172.66. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $244.49.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The business had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the business earned $2.00 earnings per share. DaVita’s quarterly revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current year.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.